Signature Resources Capital Management’s Globus Medical GMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.98K Hold
25
– – ﹤0.01% 548
2026
Q1
$2.15K Hold
25
– – ﹤0.01% 517
2025
Q4
$2.18K Hold
25
– – ﹤0.01% 473
2025
Q3
$1.43K Hold
25
– – ﹤0.01% 449
2025
Q2
$1.48K Hold
25
– – ﹤0.01% 443
2025
Q1
$1.83K Hold
25
– – ﹤0.01% 314
2024
Q4
$2.07K Hold
25
– – ﹤0.01% 297
2024
Q3
$1.79K Hold
25
– – ﹤0.01% 309
2024
Q2
$1.71K Hold
25
– – ﹤0.01% 332
2024
Q1
$1.33K Hold
25
– – ﹤0.01% 340
2023
Q4
$1.33K Buy
+25
New +$1.22K ﹤0.01% 341

Other funds holding GMED

Signature Resources Capital Management's GMED Position: Q2 2026 in Review

Signature Resources Capital Management held its Globus Medical (GMED) position steady in Q2 2026 at 25 shares worth $1.98K. The position accounts for ﹤0.01% of the portfolio, ranked #548.

Signature Resources Capital Management first reported a position in GMED in Q4 2023 and has held it in 11 quarters since. The position peaked at $2.18K in Q4 2025. 602 funds tracked by Wall St. Rank hold GMED as of Q2 2026.

  • Signature Resources Capital Management held 25 shares of Globus Medical worth $1.98K as of Q2 2026.
  • Signature Resources Capital Management left its Globus Medical share count unchanged in Q2 2026.
  • Globus Medical made up ﹤0.01% of Signature Resources Capital Management's portfolio in Q2 2026, its #548 holding.
  • Signature Resources Capital Management first reported a position in Globus Medical in Q4 2023 and has held it in 11 quarters since.
  • Signature Resources Capital Management's Globus Medical position peaked at $2.18K in Q4 2025.
  • 602 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.

Based on Signature Resources Capital Management's 13F filing for Q2 2026, filed 14 Jul 2026.